Del Laboratories $150 million seven-year notes talked 8¼% to 8½%, to price Wednesday

By Paul A. Harris

St. Louis, Jan. 18 - Del Laboratories Inc.'s $150 million offering of seven-year senior subordinated notes (B3/CCC+) emerged with price talk of 8¼% to 8½%, according to market sources.

The notes, which mature in 2012 and are non-callable for three years, are expected to price on Wednesday.

Bear Stearns & Co. and JP Morgan are joint bookrunners. Deutsche Bank Securities is the co-manager.

Proceeds will be used to help fund the acquisition of Del Laboratories by Kelso & Co. and Church & Dwight.

Del Laboratories is a Uniondale, N.Y.-based manufacturer and marketer of over-the-counter pharmaceuticals.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.